Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Colorado Cancer Center, Aurora, Colorado Florida Cancer Specialists, Lake Mary, Florida Dartmouth Hitchcock, Lebanon, New Hampshire Brown University Health Cancer Institute, Providence, Rhode Island MD Anderson Cancer Center, Houston, Texas